Author:
Hoffmann Alexander,de Souza Lara Valente,Seifert Markus,von Raffay Laura,Haschka David,Grubwieser Philipp,Grander Manuel,Mitterstiller Anna-Maria,Nairz Manfred,Poli Maura,Weiss Günter
Abstract
IntroductionHepcidin is the systemic master regulator of iron metabolism as it degrades the cellular iron exporter ferroportin. In bacterial infections, hepcidin is upregulated to limit circulating iron for pathogens, thereby increasing iron retention in macrophages. This mechanism withholds iron from extracellular bacteria but could be of disadvantage in infections with intracellular bacteria. We aimed to understand the role of hepcidin in infections with intra- or extracellular bacteria using different hepcidin inhibitors.MethodsFor the experiments LDN-193189 and oversulfated heparins were used, which interact with the BMP6-SMAD pathway thereby inhibiting hepcidin expression. We infected male C57BL/6N mice with either the intracellular bacterium Salmonella Typhimurium or the extracellular bacterium Escherichia coli and treated these mice with the different hepcidin inhibitors.ResultsBoth inhibitors effectively reduced hepcidin levels in vitro under steady state conditions and upon stimulation with the inflammatory signals interleukin-6 or lipopolysaccharide. The inhibitors also reduced hepcidin levels and increased circulating iron concentration in uninfected mice. However, both compounds failed to decrease liver- and circulating hepcidin levels in infected mice and did not affect ferroportin expression in the spleen or impact on serum iron levels. Accordingly, both BMP-SMAD signaling inhibitors did not influence bacterial numbers in different organs in the course of E.coli or S.Tm sepsis.ConclusionThese data indicate that targeting the BMP receptor or the BMP-SMAD pathway is not sufficient to suppress hepcidin expression in the course of infection with both intra- or extracellular bacteria. This suggests that upon pharmacological inhibition of the central SMAD-BMP pathways during infection, other signaling cascades are compensatorily induced to ensure sufficient hepcidin formation and iron restriction to circulating microbes.
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference78 articles.
1. Taming the Elephant: Salmonella Biology, Pathogenesis, and Prevention;Andrews-Polymenis;Infect. Immun.,2010
2. Hepcidin-Induced Hypoferremia is a Critical Host Defense Mechanism Against the Siderophilic Bacterium Vibrio Vulnificus;Arezes;Cell Host Microbe,2015
3. Structure-Function Analysis of Ferroportin Defines the Binding Site and an Alternative Mechanism of Action of Hepcidin;Aschemeyer;Blood,2018
4. Momelotinib Inhibits ACVR1/ALK2, Decreases Hepcidin Production, and Ameliorates Anemia of Chronic Disease in Rodents;Asshoff;Blood,2017
5. LJ000328, a Novel ALK2/3 Kinase Inhibitor, Represses Hepcidin and Significantly Improves the Phenotype of IRIDA;Belot;Haematologica,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献